GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » Cyclically Adjusted FCF per Share

RVXCF (Resverlogix) Cyclically Adjusted FCF per Share : $-0.12 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Resverlogix Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Resverlogix's adjusted free cash flow per share for the three months ended in Dec. 2024 was $-0.004. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.12 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Resverlogix was 14.10% per year. The lowest was -3.20% per year. And the median was 9.65% per year.

As of today (2025-05-18), Resverlogix's current stock price is $0.025. Resverlogix's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was $-0.12. Resverlogix's Cyclically Adjusted Price-to-FCF of today is .


Resverlogix Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Resverlogix's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Cyclically Adjusted FCF per Share Chart

Resverlogix Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.20 -0.16 -0.14 -0.12

Resverlogix Quarterly Data
Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.15 -0.14 -0.13 -0.12

Competitive Comparison of Resverlogix's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Resverlogix's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Resverlogix's Cyclically Adjusted Price-to-FCF falls into.


;
;

Resverlogix Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Resverlogix's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.004/127.3637*127.3637
=-0.004

Current CPI (Dec. 2024) = 127.3637.

Resverlogix Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201501 -0.047 98.209 -0.061
201504 -0.025 99.710 -0.032
201507 -0.048 100.579 -0.061
201510 -0.027 100.500 -0.034
201601 -0.100 100.184 -0.127
201604 -0.041 101.370 -0.052
201607 -0.029 101.844 -0.036
201610 -0.083 102.002 -0.104
201701 -0.075 102.318 -0.093
201704 -0.033 103.029 -0.041
201707 -0.076 103.029 -0.094
201710 -0.035 103.424 -0.043
201801 -0.062 104.056 -0.076
201804 -0.022 105.320 -0.027
201807 -0.121 106.110 -0.145
201810 -0.052 105.952 -0.063
201901 -0.047 105.557 -0.057
201904 -0.048 107.453 -0.057
201907 -0.047 108.243 -0.055
201910 -0.028 107.927 -0.033
202001 -0.004 108.085 -0.005
202004 -0.003 107.216 -0.004
202007 -0.005 108.401 -0.006
202010 -0.008 108.638 -0.009
202103 -0.003 110.298 -0.003
202106 -0.022 111.720 -0.025
202109 -0.011 112.905 -0.012
202112 -0.001 113.774 -0.001
202203 -0.006 117.646 -0.006
202206 -0.005 120.806 -0.005
202209 -0.007 120.648 -0.007
202212 0.001 120.964 0.001
202303 -0.003 122.702 -0.003
202306 -0.003 124.203 -0.003
202309 -0.002 125.230 -0.002
202312 -0.003 125.072 -0.003
202403 -0.004 126.258 -0.004
202406 -0.003 127.522 -0.003
202409 -0.003 127.285 -0.003
202412 -0.004 127.364 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Resverlogix  (OTCPK:RVXCF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Resverlogix Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Resverlogix's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix Business Description

Industry
Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Resverlogix Headlines

From GuruFocus

Resverlogix Announces One-Year Extension of Debenture

By GlobeNewswire GlobeNewswire 04-19-2022

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix Announces Proposed Offering of Units

By GlobeNewswire GlobeNewswire 05-14-2019

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix Announces Withdrawal of Public Offering of Units

By GlobeNewswire GlobeNewswire 06-09-2018

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024